about
Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide TreatmentIntratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic NichesLabel-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium.Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells.Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency.Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research.Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.Functional Role of Matrix gla Protein in Glioma Cell Migration.Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner.Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer.Insights into molecular therapy of glioma: current challenges and next generation blueprintRevisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme.TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival.Mesenchymal stem cell-like properties of CD133+ glioblastoma initiating cellsAG488 as a therapy against gliomas.Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma.Prophylactic anticonvulsants in patients with primary glioblastoma.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.Current trends in mouse models of glioblastoma.Linking invasive motility to protein expression in single tumor cells.Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients.In vivo molecular profiling of human glioma using diffusion kurtosis imaging.Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.T Cell Exhaustion Signatures Vary with Tumor Type and are Severe in Glioblastoma.Large-scale patterning of single cells and cell clusters in hydrogels.Glial Tissue Mechanics and Mechanosensing by Glial Cells.T-Cell Dysfunction in Glioblastoma: Applying a New Framework.Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting.The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors.PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma.
P2860
Q30275623-2D3E55BE-443A-432E-A908-E6F33DAA88FFQ33844943-DF2B771D-E9DB-4186-A189-3E554179A196Q36082516-10C42934-D8BE-493C-B84E-B811B2FED829Q37008901-BA574074-B7A7-4B13-AE1A-0CC6AF35B4FEQ37106630-FE3F7209-19A4-4422-9B6E-C6BB86B04E3DQ37239904-2EDEB328-799D-4088-B3A3-78A583AA4F8BQ37622195-D0DCBCC2-0A17-442D-B631-976317194B9AQ38507706-A80446E8-88F2-40AE-9E78-3F780AFE3E26Q38593065-86F91B10-6743-4E2C-A6A8-55EECB7C38DEQ38658533-FD5238AD-FA99-49E7-9E0A-983E71A9B0D7Q38697379-B2B6DF11-AAFE-4476-A6C9-DEF906EA85FCQ38697698-A634B4D8-FE69-4349-BCEF-F2157759B255Q38778367-FE76FD7F-3BDD-4073-BB05-685968D7F6E9Q38838354-896576DA-E704-4230-8534-F90CA132FD4CQ38839352-AC5C5D24-046B-495E-9C90-3C563644192FQ39096530-BAF76569-CD49-4AF4-95CC-A23061823231Q39187306-8E4DD100-57C2-4ED2-9A3B-284FF5B45EFAQ39190733-D386D113-EF47-4368-AA38-C7EBD36E1016Q39482118-7A17937E-8E2A-45CE-8B09-12F3D1E252BCQ41809872-B454A113-57A1-4E53-A54E-01CFE4B59E1FQ42019179-4D1020CD-C180-43E0-862D-9F5C4FF2055BQ42039139-42C125F4-D144-4E65-92B8-E85467913B8CQ42700872-86302950-F541-4F3B-814C-1EDB146AD8B9Q45070460-A6A1C396-F29B-44D9-8E88-7D1E58E5AF80Q45933412-497B87C8-F6FC-4D4A-8CB5-7C4F5F7CB916Q46073319-7C2E060B-C40A-4FD7-95A2-EA28A359D98DQ46190130-D8F6009B-C8C5-4AE2-B492-9D42612F4EBAQ47169542-DA39BB0B-F7DE-42CE-B7A5-655A429694B5Q47201757-BEC45FB0-29EE-4462-AD4D-2B8119448018Q47569610-D150E430-0C95-4F04-857A-8B4F7108F65EQ47943878-0965B62F-C37D-4FDF-9AA7-627F80195874Q48251729-4C741DA6-48C1-48B9-B525-33C9FC40B0F1Q50043938-9E631EEC-072D-4FC9-983F-58E5C8370231Q51418487-DB900B9D-3315-40E6-958D-8D1E6C2A1578Q51765041-CD96A735-174E-421D-BECC-2B18E976AAC3Q52625023-8267655A-E817-4B72-83A8-71B99401FBE6Q52659354-74573DA4-79FF-42B1-8960-4DC5FFA9A714Q54965858-EB931C48-E500-48C3-BAE7-12C4433D3B79Q55136092-870C9D18-8627-468A-9832-F2EFB56AE2F5Q55139727-5F00E358-0C5E-4529-8A1B-0DD599B98616
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The evidence of glioblastoma heterogeneity.
@ast
The evidence of glioblastoma heterogeneity.
@en
type
label
The evidence of glioblastoma heterogeneity.
@ast
The evidence of glioblastoma heterogeneity.
@en
prefLabel
The evidence of glioblastoma heterogeneity.
@ast
The evidence of glioblastoma heterogeneity.
@en
P2093
P2860
P356
P1433
P1476
The evidence of glioblastoma heterogeneity.
@en
P2093
Akio Soeda
Akira Hara
Deric M Park
Shin-ichi Yoshimura
Takahiro Kunisada
Toru Iwama
P2860
P2888
P356
10.1038/SREP07979
P407
P577
2015-01-27T00:00:00Z
P5875
P6179
1035819582